Relay Therapeutics, Inc.
RLAY
$10.69
$0.555.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -276.48M | -297.59M | -311.55M | -333.39M | -337.71M |
| Total Depreciation and Amortization | 3.56M | 4.29M | 4.91M | 5.28M | 5.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.77M | 63.88M | 68.41M | 64.55M | 68.52M |
| Change in Net Operating Assets | -23.31M | -19.04M | -23.19M | -8.44M | 14.62M |
| Cash from Operations | -235.46M | -248.46M | -261.42M | -271.99M | -249.11M |
| Capital Expenditure | -410.00K | -409.00K | -637.00K | -622.00K | -2.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.21M | 186.74M | 21.08M | -8.53M | -39.07M |
| Cash from Investing | 192.80M | 186.33M | 20.45M | -9.15M | -41.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.60M | 1.47M | 220.34M | 221.23M | 270.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.60M | 1.47M | 220.34M | 221.23M | 270.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.05M | -60.65M | -20.63M | -59.91M | -20.04M |